TNFSF11 and neoplasm: For patients with giant cell tumor of the extremities with high NLR values, whatever the tumor stages are, adjuvant treatment and medication such as Denosumab (human monoclonal antibody of RANKL), combined with surgical resection are recommended to reduce the recurrence rate and improve functional recovery.